DSC3 and cancer: Supporting the trend observed with the publically available data, pyrosequencing analysis revealed frequent hypermethylation of DSC3 promoter in cancer cell lines (3/3) compared with benign cell lines (0/2) (10% methylation as a cutoff) (Figure 3B).